Evidence map›Paper›PMID 34552736›Full record

ArticleClinical case reports2021

A Case of ST-Elevation Acute Myocardial Infarction in a Nonhospitalized Patient with SARS-CoV-2 Pneumonia: Treatment with Primary Percutaneous Coronary Intervention.

Ryosuke Shimai, Shohei Ouchi, Tetsuro Miyazaki, Koji Hirabayashi, Hiroshi Abe, Kosuke Yabe, Masaaki Maki, Hiroyuki Isogai, Takeshi Wada, Dai Ozaki and 6 more

Abstract readCase Reports
In one paragraph

Article in Clinical case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ryosuke ShimaiDepartment of Cardiology Juntendo Urayasu Hospital Urayasu Japan.ORCID https://orcid.org/0000-0002-9217-4491
Shohei OuchiDepartment of Cardiology Juntendo Urayasu Hospital Urayasu Japan.
Tetsuro MiyazakiDepartment of Cardiology Juntendo Urayasu Hospital Urayasu Japan.
Koji HirabayashiDepartment of Cardiology Juntendo Urayasu Hospital Urayasu Japan.
Hiroshi AbeDepartment of Cardiology Juntendo Urayasu Hospital Urayasu Japan.
Kosuke YabeDepartment of Cardiology Juntendo Urayasu Hospital Urayasu Japan.
Masaaki MakiDepartment of Cardiology Juntendo Urayasu Hospital Urayasu Japan.
Hiroyuki IsogaiDepartment of Cardiology Juntendo Urayasu Hospital Urayasu Japan.
Takeshi WadaDepartment of Cardiology Juntendo Urayasu Hospital Urayasu Japan.
Dai OzakiDepartment of Cardiology Juntendo Urayasu Hospital Urayasu Japan.
Fuminori OdagiriDepartment of Cardiology Juntendo Urayasu Hospital Urayasu Japan.
Makoto HikiDepartment of Cardiovascular Biology and Medicine Juntendo University School of Medicine Bunkyo-ku Japan.
Kenji YaginumaDepartment of Cardiology Juntendo Urayasu Hospital Urayasu Japan.
Ken YokoyamaDepartment of Cardiology Juntendo Urayasu Hospital Urayasu Japan.
Takashi TokanoDepartment of Cardiology Juntendo Urayasu Hospital Urayasu Japan.
Tohru MinaminoDepartment of Cardiovascular Biology and Medicine Juntendo University School of Medicine Bunkyo-ku Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We experienced a case of primary percutaneous coronary intervention for ST-elevation myocardial infarction (STEMI) with coronavirus disease 2019 (COVID-19) using appropriate infection prevention protocol. However, recanalization was difficult due to severe coagulopathy. Further researches are needed to clarify optimal treatment for STEMI in patients with COVID-19.

Indexed as

coagulopathyCOVID‐19infection prevention protocolout‐of‐hospital onsetST‐elevation myocardial infarction

Identifiers

PMID34552736
PMCPMC8443410

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.